You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inactive Carrier

Showing 1 - 25 of 1,306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial in France (inactive carrier)

Completed
  • Hepatitis B
  • inactive carrier
  • Aix en Provence, France
  • +31 more
Apr 5, 2022

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Tenofovir disoproxil fumarate
  • Toronto, Ontario, Canada
    University Health Network - Toronto General Hospital
Nov 1, 2022

Hepatitis B, Hepatitis B, Chronic Trial in Bamenda

Active, not recruiting
  • Hepatitis B
  • Hepatitis B, Chronic
    • Bamenda, Northwest, Cameroon
      Mbingo Baptist Hospital
    Sep 13, 2022

    Chronic Hepatitis, B Virus, Carrier of Viral Hepatitis Type B Trial in Singapore (Peginterferon Alfa-2A)

    Unknown status
    • Chronic Hepatitis, B Virus
    • Carrier of Viral Hepatitis Type B
    • Peginterferon Alfa-2A
    • Singapore, Singapore
      National University Hospital
    Mar 17, 2019

    Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

    Withdrawn
    • Chronic Hepatitis B
    • hepatitis B immune globulin (HBIg)
    • Pegylated interferon alfa (pegIFN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 4, 2022

    Polycystic Ovary Syndrome, Metformin Trial in Dhaka (Metformin Hydrochloride)

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • Metformin
    • Metformin Hydrochloride
    • Dhaka, Bangladesh
      Department of Endocrinology, Bangabandhu Sheikh Mujib Medical Un
    Jan 9, 2023

    Social-environmental, Psychosocial, Behavioral, Clinical and

    Recruiting
    • Chronic Viral Hepatitis
    • Hepatitis B Infection
    • Interview
    • +2 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Nov 2, 2021

    Esophageal Cancer Trial (OBI-833/OBI-821)

    Recruiting
    • Esophageal Cancer
    • OBI-833/OBI-821
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 22, 2022

    HBeAg-negative CHB Patients With Indeterminate Phase

    Recruiting
    • Chronic Hepatitis b
    • Observation
    • Antiviral treatment
    • Changzhou, Jiangsu, China
    • +4 more
    Dec 21, 2022

    Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

    Completed
    • Chronic Hepatitis B
    • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
    • Amsterdam, Noord-Holland, Netherlands
      Academic Medical Center
    Mar 25, 2021

    Assessment of Long-term Effects of Tachosil

    Completed
    • Fibrin Sealant
    • Haemostasis
    • TachoSil®
    • (no location specified)
    Aug 2, 2023

    ANXA5 M2 Haplotyping in IVF Patients and Embryos

    Recruiting
    • Infertility
    • +2 more
    • M2 Test
    • North Brunswick, New Jersey
      Genomic Prediction Clinical Laboratory
    Aug 1, 2022

    Endodontically Treated Teeth Trial in Bologna (root canal filling with Ceraseal sealer)

    Completed
    • Endodontically Treated Teeth
    • root canal filling with Ceraseal sealer
    • Bologna, Emilia-Romagna, Italy
      Dental School University of Bologna
    May 10, 2022

    Genetic Predisposition to Disease Trial in Paris, Cologne (BRIDGES gene panel testing, Breast cancer risk polygenic risk score

    Completed
    • Genetic Predisposition to Disease
    • BRIDGES gene panel testing
    • +2 more
    • Paris, France
    • +1 more
    Jan 19, 2023

    DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

    Not yet recruiting
    • DDX41 Gene Mutation
    • For each person (index case or related) included in this study:
    • Bordeaux, France
    • +4 more
    Aug 28, 2023

    Prostate Cancer Trial (Multidisciplinary program)

    Not yet recruiting
    • Prostate Cancer
    • Multidisciplinary program
    • (no location specified)
    Nov 30, 2022

    Metabolism Trial in Austin (12 hours of physical inactivity, 24 hours of physical inactivity, 36 hours of physical inactivity)

    Not yet recruiting
    • Metabolism
    • 12 hours of physical inactivity
    • +2 more
    • Austin, Texas
      The University of Texas at Austin
    Sep 13, 2023

    Moderate Plaque Psoriasis Trial in Miami, Houston, San Antonio (Guselkumab, Placebo)

    Recruiting
    • Moderate Plaque Psoriasis
    • Miami, Florida
    • +3 more
    Sep 9, 2023

    Calprotectin and Ischemia Modified Albumin Serum to Measure

    Completed
    • Behçet's Diseasecases
    • Serum calprotectin and IMA concentrations
    • Mansoura, Egypt
      Mansoura University Hospital
    May 18, 2023

    C. Difficile Trial (Arm 1: Routine care, Arm 2: Preemptive C. difficile infection prevention bundle)

    Recruiting
    • C. Difficile
    • Arm 1: Routine care
    • Arm 2: Preemptive C. difficile infection prevention bundle
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Sep 23, 2022

    Alcohol Use Disorder Trial (Citicoline (cytidine diphosphate-choline), Placebo oral capsule)

    Not yet recruiting
    • Alcohol Use Disorder
    • Citicoline (cytidine diphosphate-choline)
    • Placebo oral capsule
    • (no location specified)
    May 11, 2023

    Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Crohn's Disease
    • San Diego, California
    • +134 more
    Mar 13, 2023

    Crohn Disease Trial in New York (Placebo, Bacteriophage preparation)

    Recruiting
    • Crohn Disease
    • Placebo
    • Bacteriophage preparation
    • New York, New York
      The Mount Sinai Hospital
    Jan 6, 2023

    Consortium for Optimized Integration of Bio-Artificial Blood

    Not yet recruiting
    • Hemorrhage
    • Hemodynamic Instability
    • Prospective
    • (no location specified)
    Mar 6, 2023